Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.

Filters

Filters
Filter
Custom request?
Type
Production region
Qualifications
Show more
Country of origin

Hydroxytyrosol API Manufacturers & Suppliers

1 verified results
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison

Commercial-scale Suppliers

Distributor
Produced in  China
|

Employees: 50+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: ISO9001
|
CoA

All certificates

ISO9001
CoA
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Get full market intelligence report
Get full market intelligence report
€399,-
All Hydroxytyrosol data. Full access. Full negotiation power
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

Hydroxytyrosol | CAS No: 10597-60-1 | GMP-certified suppliers

A medication that exhibits antioxidant, anti-infective, and antiplatelet properties with potential applications in oxidative stress modulation and tissue protection in clinical research.

Therapeutic categories

AlcoholsAnti-Infective AgentsAntioxidantsAntiplatelet agentsBiological FactorsCompounds used in a research, industrial, or household setting
Generic name
Hydroxytyrosol
Molecule type
small molecule
CAS number
10597-60-1
DrugBank ID
DB12771
Approval status
Investigational drug

Product Snapshot

  • Hydroxytyrosol is an oral small molecule compound
  • It is primarily investigated for its antioxidant and anti-inflammatory properties
  • The product is currently in the investigational phase and has not received FDA or EMA approval

Clinical Overview

Hydroxytyrosol (CAS number 10597-60-1) is an organic compound classified within the tyrosol group, characterized structurally by a phenethyl alcohol moiety substituted with a hydroxyl group at the 4-position of the benzene ring. It is an investigational agent primarily studied in the context of clinical research. One area of investigation includes its potential role in the prevention of breast cancer, although it is not currently approved for specific clinical indications.

The compound is recognized for its biochemical properties as an antioxidant and is categorized among alcohols, anti-infective agents, antiplatelet agents, hematologic agents, and protective agents. These classifications reflect its broad spectrum of bioactivity observed in experimental contexts, particularly related to oxidative stress modulation and potential tissue protection.

Detailed pharmacodynamic profiles and mechanism of action for hydroxytyrosol remain to be fully elucidated in the literature. Similarly, comprehensive absorption, distribution, metabolism, and excretion (ADME) data are limited, as the compound is primarily utilized within research and investigational frameworks.

Safety and toxicity profiles have not been extensively characterized to support clinical use; therefore, ongoing and future studies are critical to establish therapeutic windows, tolerability, and risk-benefit assessments. Currently, hydroxytyrosol usage is confined to research settings rather than routine pharmaceutical applications.

When sourcing hydroxytyrosol as an active pharmaceutical ingredient (API), quality control should focus on purity parameters, absence of contaminants, and consistent batch-to-batch reproducibility. Given its phenolic structure, stability considerations under various storage conditions are relevant. Suppliers must provide detailed certificates of analysis aligned with regulatory expectations for investigational compounds.

Identification & chemistry

Generic name Hydroxytyrosol
Molecule type Small molecule
CAS 10597-60-1
UNII QEU0NE4O90
DrugBank ID DB12771

Formulation & handling

  • Hydroxytyrosol is a small molecule suitable for oral formulations due to its moderate water solubility and low molecular weight.
  • Its hydrophilic character and low LogP suggest favorable absorption but potential sensitivity to oxidation during handling.
  • Stability considerations include protection from light and oxygen to prevent degradation given its phenolic structure.

Regulatory status

Hydroxytyrosol is a type of Antioxidants


Antioxidants are a vital category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a crucial role in preventing oxidative damage and promoting overall health. Oxidative stress occurs when there is an imbalance between the production of reactive oxygen species (ROS) and the body's antioxidant defense mechanisms.

Antioxidants function by neutralizing ROS and minimizing the potential harm they can cause to cells and tissues. This category includes a diverse range of compounds, such as vitamins (e.

g.

, vitamin C, vitamin E), minerals (e.

g.

, selenium, zinc), and phytochemicals (e.

g.

, polyphenols, flavonoids). These antioxidants can be obtained from natural sources like fruits, vegetables, and herbs, or they can be synthesized in laboratories for pharmaceutical use.

The role of antioxidants in the prevention and treatment of various diseases has been extensively studied. They have demonstrated the ability to reduce the risk of chronic diseases like cardiovascular disorders, cancer, and neurodegenerative conditions. Moreover, antioxidants exhibit anti-inflammatory properties, enhance immune function, and protect against age-related damage.

In the pharmaceutical industry, antioxidants are widely utilized as key ingredients in the formulation of drugs, dietary supplements, and cosmetic products. They contribute to the stability and shelf life of pharmaceutical preparations by preventing oxidative degradation. Antioxidant APIs are manufactured with strict quality control measures to ensure purity, efficacy, and safety.

In conclusion, antioxidants are essential pharmaceutical APIs that provide numerous health benefits. Their ability to counteract oxidative stress and protect cells from damage makes them a valuable component in the prevention and treatment of various diseases. The pharmaceutical industry relies on these antioxidants to enhance the quality and efficacy of their products, making them indispensable in the field of healthcare.

Hydroxytyrosol API manufacturers & distributors

Compare qualified Hydroxytyrosol API suppliers worldwide. We currently have 1 companies offering Hydroxytyrosol API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.

SupplierTypeCountryProduct originCertificationsPortfolio
Distributor
China China CoA, ISO9001757 products

When sending a request, specify which Hydroxytyrosol API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).

Use the list above to find high-quality Hydroxytyrosol API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.